Conditions Evaluated
Memory and Neurodegenerative Conditions
Alzheimer’s Disease and Related Dementias
Evaluation helps clarify the presence, pattern, and severity of memory and cognitive changes. Testing also assists in distinguishing Alzheimer’s disease from other neurological causes and guides treatment and care planning.
Mild Cognitive Impairment (MCI)
Assessment determines whether changes in memory or thinking reflect early neurodegenerative disease or other factors such as mood, stress, sleep, or normal aging. This distinction supports accurate diagnosis and long-term planning.
Dementia Differential Diagnosis
Testing helps differentiate Alzheimer’s disease, vascular dementia, frontotemporal disorders, Lewy body disease, and other causes of cognitive decline. This supports appropriate intervention and medical management.
Neurodegenerative Diseases
Evaluations clarify cognitive, behavioral, and functional changes associated with progressive neurological conditions and assist in monitoring changes over time.
Parkinson’s Disease and Movement Disorders
Assessment identifies changes in attention, thinking speed, executive abilities, and daily functioning that may occur alongside motor symptoms.
Neurological and Medical Conditions
Traumatic Brain Injury and Post-Concussive Syndrome
Evaluation identifies ongoing cognitive or emotional symptoms following concussion or head injury and helps guide recovery, rehabilitation, and return-to-work or activity planning.
Epilepsy
Testing assesses cognitive functioning related to seizure activity or treatment and supports decisions about safety, independence, and care needs.
Hydrocephalus
Evaluation helps track changes in memory, attention, and executive functioning and supports medical and surgical decision making.
Brain Tumor
Assessment provides a baseline before treatment and monitors cognitive changes related to surgery, radiation, or chemotherapy.
Cognitive Changes Related to Medical Illness
Medical conditions such as lupus, multiple sclerosis, autoimmune disease, or metabolic disorders can affect cognition, and testing clarifies the nature and extent of these changes.
Genetic Conditions
Evaluation identifies cognitive and adaptive functioning patterns associated with genetic or congenital neurological conditions.
Emotional and Psychiatric Conditions
Depression and Anxiety
These conditions can affect concentration, memory, processing speed, and motivation. Evaluation helps distinguish emotional factors from neurological or medical causes of cognitive change.
Psychiatric Disorders
Testing provides insight into cognitive functioning within the context of complex psychiatric presentations. This information supports treatment planning and helps clarify whether cognitive symptoms are related to psychiatric illness, medical factors, or both.
Attention and Neurodevelopmental Conditions
Attention Difficulties (A-D/HD in Adults)
Assessment determines whether difficulties with focus, organization, and executive functioning reflect A-D/HD. Testing also helps distinguish attention concerns from anxiety, depression, sleep issues, or medical factors.
Autism in Adults
Evaluation clarifies the presence of autism spectrum characteristics and provides guidance related to strengths, challenges, daily functioning, and support needs.
Intellectual Disability
Testing identifies cognitive and adaptive functioning strengths and limitations and assists with diagnostic clarification and planning for services or support.
- Alzheimer’s Disease
- Anxiety
- Attention Problems (A-D/HD)
- Autism
- Brain Tumor
- Cognitive Changes Related to Medical Illness
- Dementia Differential Diagnosis
- Depression
- Epilepsy
- Genetic Conditions
- Hydrocephalus
- Intellectual Disability
- Lupus
- Mild Cognitive Impairment
- Multiple Sclerosis
- Neurodegenerative Diseases
- Parkinson’s disease and other movement disorders
- Post-concussive syndrome
- Psychiatric Disorders
- Traumatic brain injury